Pubrica


Annals of Oncology, an international journal published by the ESMO and JSMO, is dedicated to publishing rapid, high-quality peer reviewed studies in innovative cancer therapies and oncology related research associated with Precision Medicine. As an International Journal, it aims to provide a platform to communicate advances in oncology that will have a positive influence on the management of patients with cancer.

The journal reports on timely advances and innovations in Clinical and Translational Oncology Research including Systemic Anticancer Therapies (i.e. Chemotherapy, Immunotherapy & Radiation), Randomised Clinical Trials, and Clinical Practice Guidelines. The Annals of Oncology editorial board is comprised of highly recognized oncologists from around the world and they use their expertise and experience to report research and evidence that will be impactful in terms of changing the way we manage patients with cancer.

Annals of Oncology

Annals of Oncology, an international journal published by the ESMO and JSMO, is dedicated to publishing rapid, high-quality peer reviewed studies in innovative cancer therapies and oncology related research associated with Precision Medicine. As an International Journal, it aims to provide a platform to communicate advances in oncology that will have a positive influence on the management of patients with cancer.

The journal reports on timely advances and innovations in Clinical and Translational Oncology Research including Systemic Anticancer Therapies (i.e. Chemotherapy, Immunotherapy & Radiation), Randomised Clinical Trials, and Clinical Practice Guidelines. The Annals of Oncology editorial board is comprised of highly recognized oncologists from around the world and they use their expertise and experience to report research and evidence that will be impactful in terms of changing the way we manage patients with cancer.

Aim and Scope

Annals of Oncology is dedicated to advancing clinical oncology by publishing research that informs cancer treatment strategies, clinical decision-making, and evidence-based practice. The journal prioritizes work that integrates clinical investigation with emerging scientific and technological developments in oncology and personalized medicine. Through the publication of original research, clinical trials, and expert guidelines, the journal supports the evolving needs of oncologists, researchers, and the global cancer care community.

Scope of the Journal includes:

  • Systemic anticancer therapies, including molecularly targeted agents and immunotherapies
  • Randomized clinical trials, including negative and practice-informing studies
  • Evidence-based oncology guidelines and consensus recommendations
  • Precision and personalized oncology research
  • Molecular pathology and biomarker-driven cancer studies
  • Bioinformatics and computational approaches in oncology
  • Advanced statistical methodologies in cancer research
  • Emerging biotechnologies relevant to oncology practice
  • Radiotherapy, surgical oncology, and pediatric oncology studies with clear clinical or conceptual impact

In addition to original research articles, Annals of Oncology publishes authoritative reviews, perspectives, clinical guidelines, and consensus statements that address both scientific advances and broader issues shaping modern oncology practice.

Submitting a manuscript to Annals of Oncology requires clear clinical relevance, methodological robustness, and strict adherence to journal standards. Our Oncology manuscript editing and  Oncology submission support services focus on improving structure, clarity, and consistency throughout the manuscript,  while oncology journal formatting and compliance checks help deliver peer-review ready oncology manuscripts. Through careful oncology journal manuscript preparation and clinical oncology research editing, we support accurate presentation of cancer research across medical oncology disciplines. These academic oncology manuscript services are designed to support successful submission and review.

Annals of Oncology

Annals of Oncology

Impact Factor

Impact Factor

65.4

SJR (SCImago Journal Rank)

SJR (SCImago Journal Rank)

19.072

CiteScore

CiteScore

70.4

Frequency

Frequency

Monthly

Submission to Acceptance

Publisher

Oxford University Press (OUP)

Acceptance Rate

Acceptance Rate

12%-15%

Key Highlights

5-Year Impact Factor

46.8

H-Index

294

Indexing

Scopus, Web of Science, PubMed, Medline.

Initial Editorial Decision

15 Days

First Post-Review Decision

28 Days

Submission to Acceptance

236 Days

Acceptance to Publication

24 Days

Publication Type

Publishes original research articles, reviews, editorials, and case reports

Open Access Model

Gold OA available.

Article Processing Charges (APC)

USD 4470 for open access

Main text

3500 words

Abstract

350 words (unstructured).

References

Up to 40 (counted in total word count)

Tables/Figures

Not strictly limited in number, but each count as 150 words towards the 3,500-word limit; longer ones may become supplementary.